ML18079A012: Difference between revisions
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
||
Line 15: | Line 15: | ||
=Text= | =Text= | ||
{{#Wiki_filter: | {{#Wiki_filter:UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 | ||
***** | |||
March 16, 2018 Mr. Robin DeLaBarre Office of Nuclear Energy, Safety | |||
& Security, Room 33200 HST Bureau of International Security | |||
& Nonproliferation U.S. Department of State 2201 C Street, NW Washington, DC 20520 | |||
==Dear Mr. DeLaBarre:== | ==Dear Mr. DeLaBarre:== | ||
Enclosed is an application (XSNM3794), dated February 22, 2018, received by the U.S. Nuclear Regulatory Commission, from the U.S. Department of Energy, National Nuclear Security Administration. | Enclosed is an application (XSNM3794), dated February 22, 2018, received by the U.S. Nuclear Regulatory Commission, from the U.S. Department of Energy, National Nuclear Security Administration. The applicant is requesting to export 4.913 kilograms of high-enriched uranium to Belgium for medical isotope production, at the Institute for Radioelements. | ||
The applicant is requesting to export 4.913 kilograms of high-enriched uranium to Belgium for medical isotope production, at the Institute for Radioelements. | Before taking action on this request, we would appreciate your views, in accordance with established procedures and from the overall perspective of the Executive Branch, as to whether the requested export meets the applicable criteria in the Atomic Energy Act of 1954, as amended. | ||
Before taking action on this request, we would appreciate your views, in accordance with established procedures and from the overall perspective of the Executive Branch, as to whether the requested export meets the applicable criteria in the Atomic Energy Act of 1954, as amended.Please note that, in an effort to "minimize risk associated with interruption in the Institute of Radioelements' supply of molybdenum-99 to meet nuclear medicine demand," the applicant has requested an expedited review of this export license application. | Please note that, in an effort to "minimize risk associated with interruption in the Institute of Radioelements' supply of molybdenum-99 to meet nuclear medicine demand," the applicant has requested an expedited review of this export license application. | ||
Smcefely, Peter J. Halpighorst/Cmef Export Controls and^Nonproliferation Branch Office of International Programs | Smcefely, Peter J. Halpighorst/Cmef Export Controls and^Nonproliferation Branch Office of International Programs | ||
==Enclosure:== | ==Enclosure:== | ||
Export License Application cc w/enclosure: | Export License Application cc w/enclosure: | ||
K. Strangis, DOE/NNSA | K. Strangis, DOE/NNSA J. Semones, DHS/CBP M. Chen, DOE/NNSA P. Dessaules, DOE/NMMSS R. Bennett, DHS/CBP J. Goodman, DOE/NNSA S. Clagett, DOC E. Sauls. DTRA J. Norles, DOE/NNSA}} |
Revision as of 16:28, 21 October 2019
ML18079A012 | |
Person / Time | |
---|---|
Site: | 11006302 |
Issue date: | 03/16/2018 |
From: | Peter Habighorst NRC/OIP/ECNP |
To: | Delabarre R US Dept of State, Bureau of International Security & Nonproliferation, US Dept of State, Office of Nuclear Energy Safety & Security Affairs |
Savoy J | |
References | |
Download: ML18079A012 (1) | |
Text
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001
March 16, 2018 Mr. Robin DeLaBarre Office of Nuclear Energy, Safety
& Security, Room 33200 HST Bureau of International Security
& Nonproliferation U.S. Department of State 2201 C Street, NW Washington, DC 20520
Dear Mr. DeLaBarre:
Enclosed is an application (XSNM3794), dated February 22, 2018, received by the U.S. Nuclear Regulatory Commission, from the U.S. Department of Energy, National Nuclear Security Administration. The applicant is requesting to export 4.913 kilograms of high-enriched uranium to Belgium for medical isotope production, at the Institute for Radioelements.
Before taking action on this request, we would appreciate your views, in accordance with established procedures and from the overall perspective of the Executive Branch, as to whether the requested export meets the applicable criteria in the Atomic Energy Act of 1954, as amended.
Please note that, in an effort to "minimize risk associated with interruption in the Institute of Radioelements' supply of molybdenum-99 to meet nuclear medicine demand," the applicant has requested an expedited review of this export license application.
Smcefely, Peter J. Halpighorst/Cmef Export Controls and^Nonproliferation Branch Office of International Programs
Enclosure:
Export License Application cc w/enclosure:
K. Strangis, DOE/NNSA J. Semones, DHS/CBP M. Chen, DOE/NNSA P. Dessaules, DOE/NMMSS R. Bennett, DHS/CBP J. Goodman, DOE/NNSA S. Clagett, DOC E. Sauls. DTRA J. Norles, DOE/NNSA